HPV (Human Papillomavirus) Study

Wellers Hill Brisbane

Please note that this study has now closed. However, we encourage you to pre-register your interest for upcoming HPV studies here.

Future Studies

Description

What to expect

Future Studies

Study details

Ages

25 to 55 years old

Duration

Approximately 30 weeks and there will be 10 in-person clinic visits.

Compensation

Study treatment is provided free of charge and eligible participants will be reimbursed for study visits and reasonable study-related travel expenses.

Eligibility Criteria

You may be eligible to participate if you:

Are a female or person with a cervix, aged 25 to 55.
Have at least one test showing a positive high-risk HPV result (such as HPV 16+, HPV 18+ or HPV 12 Other +) at least 12 months before screening.
Are in generally good health

Other inclusion and exclusion criteria apply.

Locations

Wellers Hill Brisbane

Description

Human papillomavirus (HPV) is the most common sexually transmitted infection, and it is estimated that 85% of all women will be infected during their lifetime, often without experiencing symptoms.

Some types of HPV are called high risk HPV as they are associated with an increased risk of cervical cancer which is the fourth most common cancer in women.

Currently, there are no approved therapeutic treatments for high-risk HPV infections.

What to expect

We are conducting a study looking at a new investigational treatment for HPV that aims to eliminate HPV infection in affected cells.

This study has been approved by Central Adelaide Local Health Network Human Research Ethics Committee (CALHN HREC)

Study treatment is provided free of charge and eligible participants will be reimbursed for study visits and reasonable study-related travel expenses.

This study is now closed

Please note that this study has now closed. However, we encourage you to pre-register your interest for upcoming HPV studies here.

HPV Studies

Home
Clinical Trials
HPV Study Brisbane WH 22

HPV (Human Papillomavirus) Study

Wellers Hill Brisbane

Please note that this study has now closed. However, we encourage you to pre-register your interest for upcoming HPV studies here.

Future Studies

Description

What to expect

Future Studies

Study details

Ages

25 to 55 years old

Duration

Approximately 30 weeks and there will be 10 in-person clinic visits.

Compensation

Study treatment is provided free of charge and eligible participants will be reimbursed for study visits and reasonable study-related travel expenses.

Eligibility Criteria

You may be eligible to participate if you:

Are a female or person with a cervix, aged 25 to 55.
Have at least one test showing a positive high-risk HPV result (such as HPV 16+, HPV 18+ or HPV 12 Other +) at least 12 months before screening.
Are in generally good health

Other inclusion and exclusion criteria apply.

Locations

Wellers Hill Brisbane

Description

Human papillomavirus (HPV) is the most common sexually transmitted infection, and it is estimated that 85% of all women will be infected during their lifetime, often without experiencing symptoms.

Some types of HPV are called high risk HPV as they are associated with an increased risk of cervical cancer which is the fourth most common cancer in women.

Currently, there are no approved therapeutic treatments for high-risk HPV infections.

What to expect

We are conducting a study looking at a new investigational treatment for HPV that aims to eliminate HPV infection in affected cells.

This study has been approved by Central Adelaide Local Health Network Human Research Ethics Committee (CALHN HREC)

Study treatment is provided free of charge and eligible participants will be reimbursed for study visits and reasonable study-related travel expenses.

This study is now closed

Please note that this study has now closed. However, we encourage you to pre-register your interest for upcoming HPV studies here.

HPV Studies